Overview of the development of quinolone resistance in Salmonella species in China, 2005-2016.

作者: Qifa Song , Zhaojun Xu , Hong Gao , Danyang Zhang

DOI: 10.2147/IDR.S157460

关键词:

摘要: Purpose Several factors contribute to the complexity of quinolone resistance in Salmonella, including >2000 different Salmonella serotypes, a variety hosts for and wide use quinolones human beings animals. We thus aimed obtain an overview development relevant molecular mechanisms such species. Materials methods A total 1,776 isolates were collected Ningbo, China, between 2005 2016. Antimicrobial susceptibility genetic these retrospectively analyzed. Results The ratio ciprofloxacin (CIP) resistant:reduced CIP susceptible:CIP susceptible was 26:522:1,228. found nine 51 serotypes: Derby, London, Kentucky, Indiana, Corvallis, Rissen, Hadar, Typhimurium, Agona. Of 26 CIP-resistant isolates, all concurrently resistant ampicillin 21 also cefotaxime produced extended-spectrum β-lactamase (ESBL). minimal inhibitory concentration values at three levels: 2-4 μg/mL (serotypes except Kentucky Indiana), 16 (one isolate), >32 (Indiana isolates). As with most common Typhi showed quickly increased prevalence reduced recent years, Enteritidis remained high throughout study period, several Typhimurium CIP. Transferable plasmid-mediated gene qnrB only isolates. In contrast, gyrA mutations often CIP-susceptible not necessarily Conclusion conclude that there exists low resistance, which focuses on serotypes. Our demonstrates that, rather than mutations, is indicator resistance.

参考文章(8)
Mitra U, Dutta S, Dutta P, Chatterjee Mk, Bhattacharya Sk, De A, Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian Journal of Medical Research. ,vol. 113, pp. 210- ,(2001)
Anna Fàbrega, Sergi Madurga, Ernest Giralt, Jordi Vila, Mechanism of action of and resistance to quinolones Microbial Biotechnology. ,vol. 2, pp. 40- 61 ,(2009) , 10.1111/J.1751-7915.2008.00063.X
Etienne Giraud, Sylvie Baucheron, Axel Cloeckaert, Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies Microbes and Infection. ,vol. 8, pp. 1937- 1944 ,(2006) , 10.1016/J.MICINF.2005.12.025
N.W.S. Lo, M.T. Chu, J.M. Ling, Increasing quinolone resistance and multidrug resistant isolates among Salmonella enterica in Hong Kong. Journal of Infection. ,vol. 65, pp. 528- 540 ,(2012) , 10.1016/J.JINF.2012.08.016
Monique I Andersson, Alasdair P MacGowan, Development of the quinolones. Journal of Antimicrobial Chemotherapy. ,vol. 51, pp. 1- 11 ,(2003) , 10.1093/JAC/DKG212
Katie L. Hopkins, Robert H. Davies, E. John Threlfall, Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments International Journal of Antimicrobial Agents. ,vol. 25, pp. 358- 373 ,(2005) , 10.1016/J.IJANTIMICAG.2005.02.006
R.-J. Hassing, W. H. F. Goessens, D. J. Mevius, W. Pelt, J. W. Mouton, A. Verbon, P. J. Genderen, Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 32, pp. 1295- 1301 ,(2013) , 10.1007/S10096-013-1878-9
Jiansen Gong, Chengming Wang, Shourong Shi, Hongduo Bao, Chunhong Zhu, Patrick Kelly, Linlin Zhuang, Guangwu Lu, Xinhong Dou, Ran Wang, Bu Xu, Jianmin Zou, Highly Drug-Resistant Salmonella enterica Serovar Indiana Clinical Isolates Recovered from Broilers and Poultry Workers with Diarrhea in China Antimicrobial Agents and Chemotherapy. ,vol. 60, pp. 1943- 1947 ,(2016) , 10.1128/AAC.03009-15